Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Glaxo Wellcome granted license to Cellegy orphan drug

Dec. 16, 1996

Advanced Polymer Systems to supply Johnson & Johnson with Microsponge-entrapped AHAs

Dec. 16, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

Vertex selects lead development candidate for autoimmune diseases

Dec. 13, 1996

hu1124 advances to clinical studies

Dec. 12, 1996

OsmoCyte approved for marketing in U.S.

Dec. 9, 1996

Dusa photodynamic therapy advances to phase III

Dec. 9, 1996

Moisture-managing foam wound dressing introduced

Dec. 5, 1996

Treatment options for photodamaged skin

Dec. 3, 1996

Aquaphore ointment protects premature infants from dermatological infections

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...